TMC (Tumor Marker Control) Base Serum

<strong>TMC (Tumor Marker Control) Base Serum</strong>_x000D_ <strong>Catalog number:</strong> B2015054_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> TMC (Tumor Marker Control) Base Serum_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Gasparri R, Romano R, Sedda G, Borri A, Petrella F, Galetta D, Casiraghi M, Spaggiari L. Diagnostic biomarkers for lung cancer prevention J Breath Res. 2018 Feb 6;12(2):027111._x000D_ 2: Kopreski MS, Benko FA, Gocke CD. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum Ann N Y Acad Sci. 2001 Sep;945:172-8._x000D_ 3: Konturek PC, Rembiasz K, Burnat G, Konturek SJ, Tusinela M, Bielanski W, Rehfeld J, Karcz D, Hahn E. Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer Dig Dis Sci. 2006 Apr;51(4):779-87._x000D_ 4: Vojdani S, Ghaderian SMH, Zali A, Rakhshan A, Oraee Yazdani S, Poursheikhani A, Bidari Zerehpoush F, Sharifi G. Altered expression of EGFR and miR-34a derived from serum and tumoral tissue was associated with glioblastoma multiform Exp Mol Pathol. 2021 Aug;121:104655._x000D_ 5: Li X, Yue ZC, Zhang YY, Bai J, Meng XN, Geng JS, Fu SB. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer J Clin Lab Anal. 2008;22(3):164-71._x000D_ 6: Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK, Yu ZS. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer J Int Med Res. 2012;40(3):859-66._x000D_ 7: Utomo WK, Janmaat VT, Verhaar AP, Cros J, Lévy P, Ruszniewski P, den Berg MS, Jenster G, Bruno MJ, Braat H, Fuhler GM, Peppelenbosch MP. DNA integrity as biomarker in pancreatic cyst fluid Am J Cancer Res. 2016 Aug 1;6(8):1837-41. eCollection 2016._x000D_ 8: El-Arab LR, Swellam M, El Mahdy MM. Metronomic chemotherapy in metastatic breast cancer: impact on VEGF J Egypt Natl Canc Inst. 2012 Mar;24(1):15-22._x000D_ 9: Hassaneen NH, Hemeda SA, El Nahas AF, Fadl SE, El-Diasty EM. Ameliorative effects of camel milk and silymarin upon aflatoxin B1 induced hepatic injury in rats Sci Rep. 2023 Sep 12;13(1):15092._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/35670541">10: Xu L, Zhao W, Pu J, Wang S, Liu S, Li H, Yu R. A Pax-5a gene analysis approach enabled by selective digestion with lambda exonuclease Anal Methods. 2022 Jun 23;14(24):2415-2422. </a>_x000D_ _x000D_ <strong>Products Related to TMC (Tumor Marker Control) Base Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>